James E. Flynn, Director: Larimar Therapeutics LRMR Buy · Filed 24/02/16

Trade details

Type: Insider buy
Amount: $12,500,000.44
Shares · price: 1,430,206 sh · $8.74 a share
Held after: 6,151,389 sh
Stock: Larimar Therapeutics LRMR
Person: James E. FlynnDirector
Trade date: 24/02/16
Filed: 24/02/16
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 12 insiders
Holding change: +30.3%

Larimar Therapeutics trades, last 26 weeks

What else happened in Larimar Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/17~24/03/17

James E. Flynn's recent trades

James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$10M
2,000,000 sh
$10M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,012 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$5.4M
1,084,010 sh
$5.4M
Filed 03/02
Traded 02/27
James E. FlynnDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$4.2M
831,978 sh
$4.2M
Filed 03/02
Traded 02/27
James E. FlynnDirector
SellNuvalent
Sell
Nuvalent
NUVL
$35.4M
371,287 sh
$35.4M
Filed 25/11/24
Traded 25/11/24

James E. Flynn, Director — bought $12.5M of Larimar Therapeutics LRMR · 1,430,206 sh @ $8.74 | Whalegun